Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hypertension
Biotech
Mineralys stock jumps as hypertension drug posts double wins
Mineralys Therapeutics enjoyed a big stock bump after its aldosterone synthase inhibitor chalked up wins in two types of hypertension.
James Waldron
Mar 10, 2025 9:13am
Boston Scientific snags renal denervation developer SoniVie
Mar 3, 2025 11:15am
Idorsia's Tryvio sale behind schedule, but layoffs on track
Dec 20, 2024 4:42am
AI spots high blood pressure, diabetes in slow-motion video
Nov 18, 2024 11:30am
FDA clears Omron blood pressure cuff with afib detection
Nov 14, 2024 9:00am
CMS to pay for renal denervation from Medtronic, Recor Medical
Nov 6, 2024 4:45am
